基本信息
浏览量:110
职业迁徙
个人简介
Rob Hoeben has a keen interest in development and clinical translation of viral tools for gene and stem cell therapy. He has a long-term expertise in viruses for gene therapy. Initially his work focused on retrovirus and adenovirus-derived vectors for gene therapy of hemophilia A. In parallel, he generated new cell lines for the production of adenoviruses, such as the 911 cell line for production of research grade viruses and, in collaboration with scientist at Crucell, the PER.C6 cell line for clinical grade products. Later he embraced the use of mammalian reoviruses. His lab pioneered a strategy for their genetic modification allowing the construction of a replication-competent genetically retargeted reovirus.
研究兴趣
论文共 253 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCER GENE THERAPYno. 1 (2024): 58-68
Molecular oncology (2024)
Cancer research communicationsno. 2 (2023): 325-337
引用1浏览0WOS引用
1
0
Thijs J. Janssen,Geertje van der Horst, Arjanneke F. van der Merbel,Maaike van der Mark, Martine L.M. Lamfers, Bernadette G. van den Hoogen, Sjoerd S. van der Burg, Dana A. M. Mustafa,Niven Mehra,Tilly Aalders,Nadine van Montfoort,Jack A. Schalken,
Cancer Researchno. 7_Supplement (2023): 1802-1802
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn